Kovai Medical Sells Allied Health Division for ₹85 Lakh to Focus on Core Services

Kovai Medical Center & Hospital Ltd is selling its Allied Health Sciences (AHS) courses division to Dr NGP Research and Educational Trust for ₹84.54 lakh, a move aimed at sharpening the company's focus on its core healthcare operations. The transaction, structured as a slump sale, is expected to be finalized by November 30, 2026.

Transaction Details

The company's board has approved the sale of the AHS division. The sale price is ₹84.54 lakh (approximately ₹0.85 crore). For the fiscal year 2025, the AHS division reported a turnover of ₹3.96 crore and a net worth of ₹-3.39 crore. In contrast, Kovai Medical Center & Hospital Ltd's consolidated total turnover for FY25 stood at ₹1,371.11 crore, with a net worth of ₹1,085.32 crore. The slump sale includes the transfer of associated assets, liabilities, students, and employees.

Strategic Rationale

This divestment allows Kovai Medical Center & Hospital Ltd to concentrate its resources and efforts on its primary healthcare services and core medical education programs. It is also a response to new regulatory requirements for Allied Health Sciences programs, introduced by the National Commission for Allied and Healthcare Professions Act, 2021. This legislation necessitates increased compliance and a more specialized approach, prompting the company to reassess its divisional strategy and streamline operations for greater efficiency.

Related Party Concerns

A potential conflict of interest has been noted, as promoter group directors serve as trustees for the buyer, Dr NGP Research and Educational Trust. Although the company asserts that the transaction is conducted on an arm's length basis and has been supported by independent valuation, related party transactions always warrant close monitoring by investors.

Industry Context

Hospital chains like Apollo Hospitals and Fortis Healthcare are also refining their operational strategies, often prioritizing core clinical services and high-value medical offerings. Many healthcare providers are exploring divestments of non-core educational or support divisions to enhance focus. While these peers may maintain or develop their own educational arms, their divestment strategies can vary significantly in scope and scale.

Key Next Steps

Investors and observers will be tracking the execution of the Business Transfer Agreement (BTA), which has a proposed deadline of May 31, 2026. The progress toward the anticipated slump sale completion by November 30, 2026, will also be monitored, alongside any further regulatory approvals required. Ultimately, the success of this divestment will be assessed by KMCH's ability to improve resource efficiency and enhance overall returns post-sale.